Unanswered questions over NHS health checks

Putting Prevention First-vascular Checks: Risk Assessment and Management, (2008)

The Learning Network, (2010)

Economic Modelling for Vascular Checks, (2008)

Sheridan S.L., Crespo E., Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature, BMC Health Services Research, 8, (2008)

Risk factor changes and mortality results, JAMA, 24, pp. 1465-1477, (1982)

Haq I.U., Yeo W., Jackson P.R., Interventions in OXCHECK study waste resources, BMJ, 311, (1995)

Cardiovascular Risk Assessment: The Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease, (2007)

Chamnan P., Simmons R.K., Khaw K.T., Wareham N., Griffin S.J., Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: Modelling study, BMJ, 340, (2010)

Stamatakis E., Hamer E., Primatesta P., Cardiovascular medication, physical activity and mortality: Cross-sectional population study with ongoing mortality follow-up, Heart, 95, pp. 448-453, (2009)

Gillies C.L., Abrams K.R., Lambert P.C., Cooper N.J., Sutton A.J., Hsu R.T., Et al., Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: Systematic review and meta-analysis, BMJ, 334, (2007)

Putting Prevention First-vascular Checks: Risk Assessment and Management, (2008)

The Learning Network, (2010)

Economic Modelling for Vascular Checks, (2008)

Sheridan S.L., Crespo E., Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature, BMC Health Services Research, 8, (2008)

Risk factor changes and mortality results, JAMA, 24, pp. 1465-1477, (1982)

Haq I.U., Yeo W., Jackson P.R., Interventions in OXCHECK study waste resources, BMJ, 311, (1995)

Cardiovascular Risk Assessment: The Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease, (2007)

Chamnan P., Simmons R.K., Khaw K.T., Wareham N., Griffin S.J., Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: Modelling study, BMJ, 340, (2010)

Stamatakis E., Hamer E., Primatesta P., Cardiovascular medication, physical activity and mortality: Cross-sectional population study with ongoing mortality follow-up, Heart, 95, pp. 448-453, (2009)

Gillies C.L., Abrams K.R., Lambert P.C., Cooper N.J., Sutton A.J., Hsu R.T., Et al., Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: Systematic review and meta-analysis, BMJ, 334, (2007)